ScoreWhy is Ipca Laboratories Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.04 times
2
Poor long term growth as Operating profit has grown by an annual rate 4.36% of over the last 5 years
3
With a growth in Operating Profit of 27.55%, the company declared Very Positive results in Sep 25
- The company has declared positive results for the last 6 consecutive quarters
- OPERATING CF(Y) Highest at Rs 1,321.32 Cr
- PAT(Latest six months) At Rs 557.96 cr has Grown at 32.31%
- ROCE(HY) Highest at 17.89%
4
With ROE of 13.2, it has a Fair valuation with a 5 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -1.89%, its profits have risen by 59.6% ; the PEG ratio of the company is 0.6
5
High Institutional Holdings at 47.2%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Ipca Labs should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Ipca Labs for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Ipca Labs
-4.27%
-0.05
34.92%
Sensex
4.25%
0.45
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.55%
EBIT Growth (5y)
4.36%
EBIT to Interest (avg)
48.71
Debt to EBITDA (avg)
0.85
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.98
Tax Ratio
29.31%
Dividend Payout Ratio
13.76%
Pledged Shares
0
Institutional Holding
47.20%
ROCE (avg)
18.54%
ROE (avg)
12.01%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
38
Industry P/E
34
Price to Book Value
4.98
EV to EBIT
25.49
EV to EBITDA
19.96
EV to Capital Employed
4.96
EV to Sales
3.95
PEG Ratio
0.63
Dividend Yield
0.14%
ROCE (Latest)
19.48%
ROE (Latest)
13.19%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend22What is working for the Company
OPERATING CF(Y)
Highest at Rs 1,321.32 Cr
PAT(Latest six months)
At Rs 557.96 cr has Grown at 32.31%
ROCE(HY)
Highest at 17.89%
INVENTORY TURNOVER RATIO(HY)
Highest at 3.72 times
NET SALES(Q)
Highest at Rs 2,556.50 cr
PBDIT(Q)
Highest at Rs 544.92 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 21.32%
PBT LESS OI(Q)
At Rs 421.98 cr has Grown at 32.8% (vs previous 4Q average
EPS(Q)
Highest at Rs 11.14
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 263.80 cr
Loading Valuation Snapshot...
Here's what is working for Ipca Labs
Operating Cash Flow - Annually
Highest at Rs 1,321.32 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 324.75 cr has Grown at 46.9% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 221.01 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Inventory Turnover Ratio- Half Yearly
Highest at 3.72 times and Grown
each half year in the last five half yearly periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales - Quarterly
Highest at Rs 2,556.50 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 544.92 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 21.32%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 421.98 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 421.98 cr has Grown at 32.8% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 317.87 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 324.75 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 11.14
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Ipca Labs
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 263.80 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
